John Koreth, M.B.B.S., D.Phil

Dana-Farber Cancer InstituteBoston, Massachusetts - 02115 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2007

Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
December 2007 - December 2010
Neoplasms
Hematologic Neoplasms
Clinimacs Cd25 Reagent Device



